1 "S. Hamid Sayer, Md" clinical study found.

• A Phase III International Randomized Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome ...

  The study's primary objective [in a population of patients with MDS after failure of treatment with azacitidine (AZA) or ...

  Exact  Phase N/A